1-minute bits on Foresight
Foresight Institute is a non-profit organization that was founded in 1986 on a vision of coming revolutions in technology that will bring extraordinary opportunities, as well as unprecedented challenges: “If we push in the right directions — learning, teaching, arguing, shifting directions, and pushing further — then we may yet steer the technology race toward a future with room enough for our dreams.” —K. Eric Drexler, Engines of Creation
Advancing nanotechnology, biotechnology, and computer science for the long-term benefit of life.
Updates
We invite you to join our Six Months In Member Gathering! Happening June 25th, check out more here: mailchi.mp/foresight/six-months-in-member-gathering
Thank you so much to Tina Kaarsberg, Technology Manager at the Department of Energy for joining the Foresight Molecular Machines group to give us an overview of the Advanced Manufacturing Office's program in atomically precise manufacturing and nanocarbon metals.
Video is now up on our Youtube channel!
www.youtube.com/watch?v=VhG0_KkXWwk&list=PLH78wfbGI1x3hjH8RKrgoT6pgUG-k0vdI&index=4
2021 Foresight Fellow in Biologically Inspired Engineering
Tom has a Ph.D. in chemical engineering and is working as a postdoctoral fellow in Joanna Aizenberg’s lab at Harvard since 2018.
Tom is interested in the ways in which biological macromolecules mediate ion transport in living systems to produce emergent functions that enable complex life. For example, the opening and closing of ion channels in insulating membranes underlies the function of the nervous system, and the precise deposition of salts from solution onto protein templates enables the formation of skeletal structures such as bone with controlled morphologies.
He seeks to learn from these processes and apply the lessons to the design of synthetic materials. His current research focuses on using responsive chemistry and polymer physics to control the generation of electrical signals and the growth of crystals in polymeric systems.
aizenberglab.seas.harvard.edu/people/thomas-schroeder
James Peyer, CEO and founder of Cambrian Biopharma, shares his overview of the longevity biotech industry with insights into what it actually means to be a longevity biotech company, how Cambrian functions, what a DisCo model is and why it will most likely replace single asset biotech companies model, and also the barriers that he sees are preventing us from starting clinical trials with the first geroprotectors.
foresight.org/salon/james-peyer-cambrian-bio-how-to-fund-and-build-geroprotectors/
James Peyer | Cambrian Bio: How to Fund and Build Geroprotectors
foresight.org
James Peyer is the Chief Executive Officer and Co-Founder of Cambrian Biopharma. He also serves as the Chairman of the Board of Sensei Biotherapeutics...
Huge thanks to Aubrey de Grey from SENS for hosting this Foresight Biotech & Health Extension session on whether we are optimally leveraging the longevity potential of COVID-19. Check out the video here:
www.youtube.com/watch?v=xChdskcpNpg&list=PLH78wfbGI1x0Bpmq40HEVtYGj_CsEfHSk&index=2
How do we get from Satellite Tech to Long-term Space Exploration? Can Neurogenesis help us grow new Brain Cells? What is State of the Art in Quantum Computing right now?
To dive into these revolutions in technology and research, we invite you to join us this June 25th for a silo-busting 90 minutes full of inspiration to celebrate that Foresight’s focus groups on Biotechnology & Health Extension, Molecular Machines, Intelligent Cooperation, and Existential Hope have been up and running for as long!
See the full program here: foresight.org/six-months-in/
If you are not already a member, make sure you join us by following the steps here: foresight.org/donate/
